Cesarean delivery in nulliparous women for failed oxytocin-augmented labor: route of delivery in subsequent pregnancy.
Fifty-eight patients experienced cesarean section for termination of their first term pregnancy subsequent to a failed trial of oxytocin therapy. Cephalopelvic disproportion and "failure to progress" were the sole indications for the initial cesarean section. All 58 women returned to our hospital for a subsequent trial of labor during the years 1977-1979 inclusive, and 40 of the 58 were able to have a vaginal delivery. Parameters investigated included first and subsequent pregnancy birth weights; birth weight difference; duration and maximal dose of oxytocin; status of the cervix at admission, prior to oxytocin, and before cesarean section; and the clinical and/or radiologic estimation of pelvic dimensions. Subsequent birth weight less than 3,500 gm was the only statistically significant factor associated with a high rate of vaginal delivery.
D001724:Birth Weight; D002585:Cesarean Section; D036861:Delivery, Obstetric / Q000379:methods*; D005260:Female; D006801:Humans; D007744:Obstetric Labor Complications; D010121:Oxytocin / Q000008:administration & dosage; D011247:Pregnancy; D012086:Reoperation
D010121:Oxytocin